These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9028727

  • 21. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets.
    Weinhaus AJ, Stout LE, Sorenson RL.
    Endocrinology; 1996 May; 137(5):1640-9. PubMed ID: 8612496
    [Abstract] [Full Text] [Related]

  • 22. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat.
    Jörns A, Klempnauer J.
    Exp Clin Endocrinol Diabetes; 1995 May; 103 Suppl 2():103-6. PubMed ID: 8839264
    [Abstract] [Full Text] [Related]

  • 23. Pancreatic beta-cells express a low affinity glucose transporter: functional consequences in normal and diabetic states.
    Marshall MO, Thomas HM, Seatter MJ, Greer KR, Wood PJ, Gould GW.
    Biochem Soc Trans; 1993 Feb; 21(1):164-8. PubMed ID: 8449285
    [Abstract] [Full Text] [Related]

  • 24. Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat).
    Jörns A, Tiedge M, Ziv E, Shafrir E, Lenzen S.
    Virchows Arch; 2002 Jan; 440(1):63-9. PubMed ID: 11942578
    [Abstract] [Full Text] [Related]

  • 25. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.
    De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F.
    J Clin Invest; 1995 Nov; 96(5):2489-95. PubMed ID: 7593639
    [Abstract] [Full Text] [Related]

  • 26. The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment.
    Thorens B, Wu YJ, Leahy JL, Weir GC.
    J Clin Invest; 1992 Jul; 90(1):77-85. PubMed ID: 1634622
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of oleic acid deterioration in insulin secretion: role in the pathogenesis of type 2 diabetes.
    Zhang Y, Xiao M, Niu G, Tan H.
    Life Sci; 2005 Sep 09; 77(17):2071-81. PubMed ID: 15935394
    [Abstract] [Full Text] [Related]

  • 28. Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.
    Kooptiwut S, Zraika S, Thorburn AW, Dunlop ME, Darwiche R, Kay TW, Proietto J, Andrikopoulos S.
    Endocrinology; 2002 Jun 09; 143(6):2085-92. PubMed ID: 12021173
    [Abstract] [Full Text] [Related]

  • 29. Beta cell dysfunction in non-insulin-dependent diabetes mellitus.
    Gray H, O'Rahilly S.
    Transplant Proc; 1994 Apr 09; 26(2):366-70. PubMed ID: 8171465
    [No Abstract] [Full Text] [Related]

  • 30. Present and potential future use of gene therapy for the treatment of non-insulin dependent diabetes mellitus (Review).
    Freeman DJ, Leclerc I, Rutter GA.
    Int J Mol Med; 1999 Dec 09; 4(6):585-92. PubMed ID: 10567666
    [Abstract] [Full Text] [Related]

  • 31. Engineering of a glucose-responsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes.
    Tiedge M, Elsner M, McClenaghan NH, Hedrich HJ, Grube D, Klempnauer J, Lenzen S.
    Hum Gene Ther; 2000 Feb 10; 11(3):403-14. PubMed ID: 10697115
    [Abstract] [Full Text] [Related]

  • 32. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S, Kebede M, Zraika S, Visinoni S, Aston-Mourney K, Favaloro J, Tikellis C, Thomas MC, Forbes JM, Cooper ME, Dunlop M, Proietto J, Andrikopoulos S.
    J Mol Endocrinol; 2005 Aug 10; 35(1):39-48. PubMed ID: 16087720
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of glucose sensing and multiplicity of glucose sensors.
    Thorens B.
    Ann Endocrinol (Paris); 2004 Feb 10; 65(1):9-12. PubMed ID: 15122086
    [No Abstract] [Full Text] [Related]

  • 34. Regulation of pancreatic B-cell glucokinase and GLUT2 glucose transporter gene expression.
    Lenzen S, Tiedge M.
    Biochem Soc Trans; 1994 Feb 10; 22(1):1-6. PubMed ID: 8206196
    [No Abstract] [Full Text] [Related]

  • 35. Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM.
    Ferrer J, Benito C, Gomis R.
    Diabetes; 1995 Dec 10; 44(12):1369-74. PubMed ID: 7589840
    [Abstract] [Full Text] [Related]

  • 36. The relationship of diabetes, loss of glucose-induced insulin secretion, and GLUT2.
    Weir GC.
    J Diabetes Complications; 1993 Dec 10; 7(2):124-9. PubMed ID: 8518454
    [Abstract] [Full Text] [Related]

  • 37. [Various molecular mechanisms involved in the pathogenesis of type II diabetes and their potential therapeutic importance].
    Waeber G, Nicod P.
    Schweiz Med Wochenschr; 1992 Jul 25; 122(30):1109-16. PubMed ID: 1496338
    [Abstract] [Full Text] [Related]

  • 38. UCP2 mRNA expression is dependent on glucose metabolism in pancreatic islets.
    Dalgaard LT.
    Biochem Biophys Res Commun; 2012 Jan 06; 417(1):495-500. PubMed ID: 22177951
    [Abstract] [Full Text] [Related]

  • 39. [Glucokinase].
    Eto K, Kadowaki T.
    Nihon Rinsho; 2002 Jul 06; 60 Suppl 7():523-34. PubMed ID: 12238093
    [No Abstract] [Full Text] [Related]

  • 40. [Dysfunction of the pancreatic beta cells observed in non-insulin-dependent diabetes].
    Waeber G.
    Rev Med Suisse Romande; 1993 Sep 06; 113(9):695-8. PubMed ID: 8210896
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.